EW vs JAMF · P/E 47, rev $1.39B vs rev $627.4M
Edwards Lifesciences Corp (EW) versus Jamf Holding (JAMF) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Jamf Holding (JAMF) is a software - application company listed on US.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported JAMF revenue for 2024-12-31 was $627.4M. Net income was -$68.5M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. JAMF currently screens at market cap $1.25B.
EW currently screens at market cap $49.91B and trailing P/E 46.9. JAMF currently screens at market cap $1.25B.
Not investment advice. Open the EW and JAMF stock pages for the full models.
Not investment advice.